THNR vs. FAAR

Last updated Jun 24, 2026

THNR (Amplify Weight Loss Drug & Treatment ETF) and FAAR (First Trust Alternative Absolute Return Strategy ETF) are both exchange-traded funds - THNR is a Health & Biotech Equities fund tracking the VettaFi Weight Loss Drug & Treatment Index, while FAAR is a Commodities fund actively managed by First Trust. THNR is passively managed, while FAAR is actively managed. Over the past year, THNR returned 12.04% vs 28.33% for FAAR. At a correlation of -0.04, they often move in opposite directions. THNR charges 0.59%/yr vs 0.95%/yr for FAAR.

Performance

THNR vs. FAAR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amplify Weight Loss Drug & Treatment ETF (THNR) and First Trust Alternative Absolute Return Strategy ETF (FAAR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, THNR achieves a -2.16% return, which is significantly lower than FAAR's 19.14% return.

THNR

• 1D: 0.96%
• 1M: -0.39%
• YTD: -2.16%
• 6M: -3.36%
• 1Y: 12.04%
• 3Y*: —
• 5Y*: —
• 10Y*: —

FAAR

• 1D: -0.91%
• 1M: -5.21%
• YTD: 19.14%
• 6M: 18.06%
• 1Y: 28.33%
• 3Y*: 10.57%
• 5Y*: 7.72%
• 10Y*: 4.69%

*Multi-year figures are annualized to reflect compound growth (CAGR)

THNR vs. FAAR - Yearly Performance Comparison

	2026 (YTD)	2025	2024
THNR Amplify Weight Loss Drug & Treatment ETF	-2.16%	13.65%	-10.47%
FAAR First Trust Alternative Absolute Return Strategy ETF	19.14%	8.07%	1.11%

Correlation

The correlation between THNR and FAAR is -0.11, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.11
Correlation (All Time) Calculated using the full available price history since May 21, 2024	-0.04

Return for Risk

THNR vs. FAAR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

THNR

THNR Risk / Return Rank: 20
THNR Sharpe Ratio Rank: 20
THNR Sortino Ratio Rank: 20
THNR Omega Ratio Rank: 19
THNR Calmar Ratio Rank: 23
THNR Martin Ratio Rank: 20

FAAR

FAAR Risk / Return Rank: 75
FAAR Sharpe Ratio Rank: 71
FAAR Sortino Ratio Rank: 74
FAAR Omega Ratio Rank: 65
FAAR Calmar Ratio Rank: 86
FAAR Martin Ratio Rank: 81

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

THNR vs. FAAR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amplify Weight Loss Drug & Treatment ETF (THNR) and First Trust Alternative Absolute Return Strategy ETF (FAAR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	THNR	FAAR	Difference
Sharpe ratio: Return per unit of total volatility	0.64	2.15	-1.52
Sortino ratio: Return per unit of downside risk	1.05	3.09	-2.05
Omega ratio: Gain probability vs. loss probability	1.12	1.37	-0.24
Calmar ratio: Return relative to maximum drawdown	1.00	4.52	-3.52
Martin ratio: Return relative to average drawdown	2.20	15.18	-12.98

THNR vs. FAAR - Sharpe Ratio Comparison

The current THNR Sharpe Ratio is 0.64, which is lower than the FAAR Sharpe Ratio of 2.15. The chart below compares the historical Sharpe Ratios of THNR and FAAR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

THNR vs. FAAR - Drawdown Comparison

The maximum THNR drawdown since its inception was -32.51%, which is greater than FAAR's maximum drawdown of -18.03%. Use the drawdown chart below to compare losses from any high point for THNR and FAAR.

Drawdown Indicators

	THNR	FAAR	Difference
Max Drawdown Largest peak-to-trough decline	-32.51%	-18.03%	-14.48%
Max Drawdown (1Y) Largest decline over 1 year	-12.06%	-6.29%	-5.77%
Max Drawdown (3Y) Largest decline over 3 years	—	-11.54%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-18.03%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-18.03%	—
Current Drawdown Current decline from peak	-10.21%	-6.29%	-3.92%
Average Drawdown Average peak-to-trough decline	-12.21%	-7.82%	-4.39%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.48%	1.87%	+3.61%

Volatility

THNR vs. FAAR - Volatility Comparison

Amplify Weight Loss Drug & Treatment ETF (THNR) has a higher volatility of 5.73% compared to First Trust Alternative Absolute Return Strategy ETF (FAAR) at 2.55%. This indicates that THNR's price experiences larger fluctuations and is considered to be riskier than FAAR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	THNR	FAAR	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.73%	2.55%	+3.18%
Volatility (6M) Calculated over the trailing 6-month period	13.69%	9.68%	+4.01%
Volatility (1Y) Calculated over the trailing 1-year period	19.03%	13.38%	+5.65%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	19.34%	12.96%	+6.38%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.34%	11.54%	+7.80%

THNR vs. FAAR - Expense Ratio Comparison

THNR has a 0.59% expense ratio, which is lower than FAAR's 0.95% expense ratio.

Dividends

THNR vs. FAAR - Dividend Comparison

THNR's dividend yield for the trailing twelve months is around 1.67%, less than FAAR's 9.66% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
FAAR First Trust Alternative Absolute Return Strategy ETF	9.66%	11.63%	3.45%	3.20%	5.82%	6.49%	3.05%	1.02%	0.58%	2.83%
THNR Amplify Weight Loss Drug & Treatment ETF	1.67%	1.64%	0.98%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both THNR and FAAR in my portfolio?

THNR and FAAR have a correlation of -0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, THNR or FAAR?

THNR has higher volatility (5.73%) compared to FAAR (2.55%). In terms of maximum drawdown, THNR dropped -32.51% vs FAAR's -18.03%.

Which ETF is better, THNR or FAAR?

On 1-year performance, FAAR leads with 28.33% vs 12.04% for THNR. On fees, THNR is cheaper at 0.59% per year. On volatility, FAAR has been the lower-risk option at 2.55%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, THNR or FAAR?

Over the 1-year period, FAAR has performed better with a 28.33% return vs 12.04%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, THNR or FAAR?

THNR is cheaper with a 0.59% expense ratio, compared with 0.95% for FAAR.

Which ETF pays a higher dividend yield, THNR or FAAR?

FAAR has the higher dividend yield at 9.66%, compared with 1.67% for THNR.

What is the main difference between THNR and FAAR?

THNR is categorized as Health & Biotech Equities, while FAAR is Commodities. They also come from different issuers: Amplify and First Trust. Their fees differ too: 0.59% for THNR and 0.95% for FAAR.

Which has better risk-adjusted returns?

FAAR currently has the higher Sharpe Ratio (2.15 vs 0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.